Loading...
Physiomics Plc
PYC.L•LSE
Healthcare
Biotechnology
£0.41
£-0.05(-10.00%)
Physiomics Plc (PYC.L) Company Profile & Overview
Explore Physiomics Plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Physiomics Plc (PYC.L) Company Profile & Overview
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
SectorHealthcare
IndustryBiotechnology
CEOPeter Joseph Sargent
Contact Information
Company Facts
11 Employees
IPO DateDec 20, 2004
CountryGB
Actively Trading